Steering Committee

Motivation. Skills. Dedication.

The Steering Committe of the Phagistry is responsible for overseeing all aspects of the registry, including the data collected, data analysis, and preparation of reports and publications. It is also responsible for communicating with Phagistry members, researchers, and the wider community.

We are currently in the process of filling the first Steering Committe of the Phagistry so check back to see some familiar - and new - faces!

Chairman

Shawna McCallin

Group leader of the Phage Therapy and Research Group at the Balgrist University Hospital, University of Zürich, Switzerland. Organizing treatments and clinical trials with phage therapy for the treatment of urinary tract infections (UTIs). Member of the executive board of the ESCMID study group for Non-Traditional Antibacterial Therapy (ESGNTA).

Vice Chairman

Sarah Djebara

Internal medicine physician. Medical doctor responsible of phage therapy coordination at the QAMH since 2017.

claßen, annika_MFK_2207 - Annika Claßen.JPG

Secretary

Annika Classen

A physician specializing in the field of infectious diseases since 2017. After joining the phage collection of the Leibniz Institute DSMZ Braunschweig (Germany) from 2021-2022 as a postdoc, she is now establishing a phage laboratory at the University of Cologne with a focus on ESKAPE pathogens.

Principal Coordinator

Lorenz Leitner

Senior physician in the Department of Neuro-Urology at the Balgrist University Hospital. Clinical lead on experimental treatments and clinical trials with phages.

Database Chair

Alexia Charles

Graduated with a doctorate from the Division of Public Health Epidemiology of the University of Liège. Current scientific collaborator for the management of data and samples for the Clinical Observational Studies unit of Sciensano, the Federal Scientific Institute of Public Health (Belgium). Administrator of Sciensano's REDCap.

Data analysis Chair

Ruby Lin

Adj Professor and Deputy Directory of Phage Australia – a program that builds on Phage Australia’s international leadership in phage therapy, microbiology, clinical and laboratory medicine, genomics, informatics and biotechnology. Expert in genomics and biotechnology.

Clinical Chair

Gina Suh

An Infectious Diseases specialist with an interest in musculoskeletal infections and other biofilm-mediated infections. Founder and director of the Mayo Clinic Phage Therapy and Lysins Program (MC-PHLY) and has treated patients with phage therapy for various indications including prosthetic joint infection, cardiac-device infection, vascular graft infection, and respiratory infection.

Microbiology Chair

Pieter-Jan Ceyssens

Leader of Belgian's quality control program on PTMPs since 2018. Chair of the EDQM working party on Bacteriophages, and board members of the Belgian Society of Viruses of Microbes.

Phage Chair

Jean-Paul Pirnay

Head of the Laboratory for Molecular and Cellular Technology (LabMCT) of the Queen Astrid Military hospital in Brussels since 2005, which includes a phage research laboratory and a cleanroom production facility for phage

preparations. Contributed to the development of a dedicated framework for personalized phage therapy in Belgium.

Scientific Advisory Board

The Scientific Advisory Board of the Phagistry combines expertise in different clinical areas with microbiology and phage and oversees various aspects of the Phagistry.

Jon Iredell

Physician and microbiologist; Lead of Phage Australia

Maria J.G.T. Vehreschild

Head of the Division of Infectious Diseases at the University Hospital Frankfurt

Saima Aslam

Professor and Clinical Lead for the UCSD Center for Innovative Phage Applications and Therapeutics (IPATH).

Ran Nir-Paz

Speciality

Tristan Ferry

Speciality